Cronos Group Inc. CEO, Mike Gorenstein, to Present at the CIBC 18th Annual Eastern Institutional Investors Conference
September 24 2019 - 8:30AM
Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative
global cannabinoid company, today announced that Mike Gorenstein,
Chairman, President and Chief Executive Officer, will speak at the
CIBC 18th Annual Eastern Institutional Investors Conference on
Wednesday September 25, 2019 at 3:25 p.m. ET in Montreal, QC.
The presentations will be available on the Investors section of
the Company’s website at
ir.thecronosgroup.com/events-presentations.
About Cronos Group Inc.
Cronos Group is an innovative global cannabinoid company with
international production and distribution across five
continents. Cronos Group is committed to building disruptive
intellectual property by advancing cannabis
research, technology and product development. With a
passion to responsibly elevate the consumer experience, Cronos
Group is building an iconic brand portfolio. Cronos Group’s
portfolio includes PEACE NATURALS™, a global health and
wellness platform, two adult-use brands, COVE™ and Spinach™, and
Lord Jones™, a hemp-derived cannabidiol (CBD) personal care
brand. To learn more about Cronos Group and its brands, please
visit: www.thecronosgroup.com; www.peacenaturals.com; www.covecannabis.ca; www.spinachcannabis.com;
www.lordjones.com
Forward-looking statements
This news release contains “forward-looking information” and
“forward-looking statements” within the meaning of applicable
Canadian and U.S. securities laws. All information
contained herein that is not clearly historical in nature may
constitute forward-looking information. In some cases,
forward-looking statements can be identified by words or phrases
such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”,
“potential”, “estimate”, “believe” or the negative of these terms,
or other similar expressions intended to identify forward-looking
statements. Some of the forward-looking statements contained in
this press release include the Company’s intention to build an
international iconic brand portfolio and develop disruptive
intellectual property. Forward-looking statements are necessarily
based upon a number of estimates and assumptions that, while
considered reasonable by management, are inherently subject to
significant business, economic and competitive risks, uncertainties
and contingencies that may cause actual financial results,
performance or achievements to be materially different from the
estimated future results, performance or achievements expressed or
implied by those forward-looking statements and the forward-looking
statements are not guarantees of future performance. A discussion
of some of the material risks applicable to the Company can be
found in the Company’s current Management’s Discussion and Analysis
and Annual Information Form, both of which have been filed on SEDAR
and EDGAR and can be accessed
at www.sedar.com and www.sec.gov/edgar,
respectively. The forward-looking information included in this news
release is made as of the date of this news release and, except as
required by law, Cronos Group disclaims any obligation to
update or revise any forward-looking statements. Readers are
cautioned not to put undue reliance on these forward-looking
statements.
For further information please contact: Anna
ShlimakInvestor RelationsTel: (416)
504-0004investor.relations@thecronosgroup.com
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Sep 2023 to Sep 2024